EPIEN Medical continues to develop its innovative, patented platform for nonbiologic, therapeutic treatments to restore and regenerate impaired epidermal and dermal tissue
EPIEN Medical, Inc. (EMI) is a privately held biomedical company headquartered in St. Paul, Minnesota, USA. The Company is focused on the global health challenges of restoring impaired skin (the bodies largest organ), including both epidermal and dermal layers. This is accomplished through a groundbreaking debridement technology based around a proprietary chemical desiccation process. Our technology platform is called Desiccation Shock Debridement Technology (“DSD”). This proprietary debridement technology is based on a cellular and a molecular process. The products are intended for use by healthcare professionals in the management of oral disease, acute and chronic wounds and burns as well veterinary care. EMI continues to explore multiple disease states that would benefit from its novel molecular and regenerative technology.
Advancing new possibilities
Our unique leadership teams bring extraordinary talents together to push forward perspectives that drive new ideas to pioneer and advance new healthcare therapies.